- Home
- ANTE vs MBRX Comparison
ANTE vs MBRX Comparison
Compare ANTE & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- MBRX
- Stock Information
- Founded
- ANTE 2005
- MBRX 2015
- Country
- ANTE China
- MBRX United States
- Employees
- ANTE N/A
- MBRX N/A
- Industry
- ANTE Advertising
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- MBRX Health Care
- Exchange
- ANTE Nasdaq
- MBRX Nasdaq
- Market Cap
- ANTE 6.7M
- MBRX 5.7M
- IPO Year
- ANTE N/A
- MBRX 2016
- Fundamental
- Price
- ANTE $0.45
- MBRX $1.75
- Analyst Decision
- ANTE
- MBRX Strong Buy
- Analyst Count
- ANTE 0
- MBRX 2
- Target Price
- ANTE N/A
- MBRX $24.00
- AVG Volume (30 Days)
- ANTE 50.9K
- MBRX 58.5K
- Earning Date
- ANTE 09-30-2024
- MBRX 11-08-2024
- Dividend Yield
- ANTE N/A
- MBRX N/A
- EPS Growth
- ANTE N/A
- MBRX N/A
- EPS
- ANTE 2.64
- MBRX N/A
- Revenue
- ANTE $500,000.00
- MBRX N/A
- Revenue This Year
- ANTE N/A
- MBRX N/A
- Revenue Next Year
- ANTE N/A
- MBRX N/A
- P/E Ratio
- ANTE $0.17
- MBRX N/A
- Revenue Growth
- ANTE N/A
- MBRX N/A
- 52 Week Low
- ANTE $0.26
- MBRX $0.40
- 52 Week High
- ANTE $2.90
- MBRX $6.24
- Technical
- Relative Strength Index (RSI)
- ANTE 49.49
- MBRX 43.16
- Support Level
- ANTE $0.42
- MBRX $1.71
- Resistance Level
- ANTE $0.47
- MBRX $1.93
- Average True Range (ATR)
- ANTE 0.04
- MBRX 0.19
- MACD
- ANTE 0.00
- MBRX 0.03
- Stochastic Oscillator
- ANTE 41.25
- MBRX 38.46
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.